CN1042132C - N－肉桂酰基－2－甲基－5－甲氧基－3－吲哚乙酸酯、其制造方法及含有这种化合物的药物组合物 - Google Patents

N－肉桂酰基－2－甲基－5－甲氧基－3－吲哚乙酸酯、其制造方法及含有这种化合物的药物组合物 Download PDF

Info

Publication number
CN1042132C
CN1042132C CN95105716A CN95105716A CN1042132C CN 1042132 C CN1042132 C CN 1042132C CN 95105716 A CN95105716 A CN 95105716A CN 95105716 A CN95105716 A CN 95105716A CN 1042132 C CN1042132 C CN 1042132C
Authority
CN
China
Prior art keywords
represent hydrogen
represent
methyl
amino
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN95105716A
Other languages
English (en)
Chinese (zh)
Other versions
CN1113243A (zh
Inventor
T·耶什
B·米尔克
U·彼得森
T·申克
K·D·布伦姆
R·恩德曼
K·G·梅茨格
M·施尔
M·施蒂格曼
H·G·韦茨坦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of CN1113243A publication Critical patent/CN1113243A/zh
Application granted granted Critical
Publication of CN1042132C publication Critical patent/CN1042132C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CN95105716A 1994-05-11 1995-05-10 N－肉桂酰基－2－甲基－5－甲氧基－3－吲哚乙酸酯、其制造方法及含有这种化合物的药物组合物 Expired - Fee Related CN1042132C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4416622A DE4416622A1 (de) 1994-05-11 1994-05-11 8-Amino-10-(azabicycloalkyl)-pyrido[1,2,3-d.e] [1,3,4]benzoxa-diazinderivate
DEP4416622.2 1994-05-11

Publications (2)

Publication Number Publication Date
CN1113243A CN1113243A (zh) 1995-12-13
CN1042132C true CN1042132C (zh) 1999-02-17

Family

ID=6517869

Family Applications (1)

Application Number Title Priority Date Filing Date
CN95105716A Expired - Fee Related CN1042132C (zh) 1994-05-11 1995-05-10 N－肉桂酰基－2－甲基－5－甲氧基－3－吲哚乙酸酯、其制造方法及含有这种化合物的药物组合物

Country Status (19)

Country Link
US (1) US5679675A (da)
EP (1) EP0682030B1 (da)
JP (1) JPH0873468A (da)
KR (1) KR950032210A (da)
CN (1) CN1042132C (da)
AT (1) ATE194351T1 (da)
AU (1) AU689212B2 (da)
CA (1) CA2148866A1 (da)
DE (2) DE4416622A1 (da)
DK (1) DK0682030T3 (da)
ES (1) ES2148372T3 (da)
GR (1) GR3034280T3 (da)
HU (1) HU219301B (da)
IL (1) IL113650A (da)
NZ (1) NZ272081A (da)
PT (1) PT682030E (da)
RU (1) RU2138504C1 (da)
TW (1) TW455589B (da)
ZA (1) ZA953776B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4427530A1 (de) * 1994-08-04 1996-02-08 Bayer Ag Chinolon- und Naphthyridoncarbonsäure-Derivate
FR2928150A1 (fr) * 2008-02-29 2009-09-04 Vetoquinol Sa Sa Nouveaux derives 7-substitues de 3-carboxy-oxadiazino-quinolones, leur preparation et leur application comme anti-bacteriens
EP2145891A1 (en) 2008-07-09 2010-01-20 Vetoquinol S.A. 9-substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4864023A (en) * 1986-09-12 1989-09-05 Hoffmann-La Roche Inc. Pyrido(3,2,1-IJ)-1,3,4-benzoxadiazine derivatives
WO1992012146A1 (fr) * 1990-12-27 1992-07-23 Banyu Pharmaceutical Co., Ltd. Derive d'acide pyridonecarboxylique

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0259804B1 (de) * 1986-09-12 1993-11-18 F. Hoffmann-La Roche Ag Pyrido [3,2,1-ij]-1,3,4-benzoxadiazinderivate, Verfahren zu deren Herstellung, entsprechende pharmazeutische Präparate und im Verfahren verwendbare Zwischenprodukte
JP2844079B2 (ja) * 1988-05-23 1999-01-06 塩野義製薬株式会社 ピリドンカルボン酸系抗菌剤
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
CA2012681A1 (en) * 1989-03-31 1990-09-30 Masayasu Okuhira Quinolone derivatives, preparation processes thereof, and antibacterial agents containing the same
DE4329600A1 (de) * 1993-09-02 1995-03-09 Bayer Ag Pyrido [1,2,3-d,e] [1,3,4] benzoxadiazinderivate
DE4416620A1 (de) * 1994-05-11 1995-11-16 Bayer Ag 8-Amino-pyrido[1,2,3-d,e][1,3,4]benzoxadiazinderivate

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4864023A (en) * 1986-09-12 1989-09-05 Hoffmann-La Roche Inc. Pyrido(3,2,1-IJ)-1,3,4-benzoxadiazine derivatives
WO1992012146A1 (fr) * 1990-12-27 1992-07-23 Banyu Pharmaceutical Co., Ltd. Derive d'acide pyridonecarboxylique

Also Published As

Publication number Publication date
IL113650A (en) 2000-02-17
AU689212B2 (en) 1998-03-26
CN1113243A (zh) 1995-12-13
PT682030E (pt) 2000-12-29
EP0682030B1 (de) 2000-07-05
US5679675A (en) 1997-10-21
IL113650A0 (en) 1995-08-31
RU95107150A (ru) 1997-02-10
DE4416622A1 (de) 1995-11-16
ES2148372T3 (es) 2000-10-16
CA2148866A1 (en) 1995-11-12
KR950032210A (ko) 1995-12-20
TW455589B (en) 2001-09-21
NZ272081A (en) 1996-05-28
DK0682030T3 (da) 2000-10-02
ATE194351T1 (de) 2000-07-15
GR3034280T3 (en) 2000-12-29
AU1633695A (en) 1995-11-16
JPH0873468A (ja) 1996-03-19
EP0682030A1 (de) 1995-11-15
HUT71611A (en) 1996-01-29
HU219301B (en) 2001-03-28
DE59508524D1 (de) 2000-08-10
RU2138504C1 (ru) 1999-09-27
ZA953776B (en) 1996-01-16

Similar Documents

Publication Publication Date Title
CN1036193C (zh) 7-未取代的或取代的氨基-5-氮杂螺(2，4)庚烷的制法
CN1178938C (zh) 1,2-稠合的喹啉衍生物
CN1075499C (zh) 喹诺酮甲酸和萘啶酮甲酸衍生物
CN1061039C (zh) 环状缩酚酸肽化合物或其盐及其制备方法和用途
CN1009930B (zh) 含喹啉羧酸衍生物的药物组合物的制备方法
CN100335054C (zh) 喹诺酮羧酸和萘啶酮羧酸衍生物在治疗幽门螺杆菌感染和其相关的胃十二指肠疾病中的应用
CN1894242A (zh) 新型噁唑烷酮衍生物
CN1031842A (zh) 新二唑
CN101076532A (zh) 作为甘氨酸转运体I(GlyT－1)抑制剂用于治疗阿尔茨海默氏病的二环和三环取代的苯甲酮化合物
CN87103138A (zh) 新的喹啉衍生物及其制备方法
CN1495183A (zh) 作为抗寄生虫药的对郝青酰胺
CN1143961A (zh) 噁唑烷酮衍生物和含有它们的药物组合物
CN1046162A (zh) 5-烷基喹诺酮羧酸
CN1037441C (zh) 二环胺衍生物及含有该衍生物的抗菌剂
CN1082051C (zh) 新的环缩肽pf1022物质的衍生物
CN1068115A (zh) 7-异二氢吲哚基-喹诺酮和-1，4二氢-1，8二氮杂萘-4-酮羧酸衍生物
CN1087341A (zh) N-取代的氨杂双环庚烷衍生物，制备和其用途
CN1894251A (zh) (6r)－l－赤型－四氢生物蝶呤二盐酸盐的晶型
CN87100354A (zh) 7-(氮杂双环烷基)-喹诺酮羧酸和7-(氮杂双环烷基)-二氮杂萘酮羧酸的衍生物
CN1422256A (zh) 包含作为活性成分的吡啶酮羧酸的抗耐酸细菌药
CN1111629A (zh) 5-乙烯基-、5-乙炔基喹诺酮羧酸类和5-乙烯基-、5-乙炔基萘啶酮羧酸类
CN1317277C (zh) 苯并呋喃衍生物及其作为药物制剂的应用
CN1173971C (zh) 环烷基取代的氨甲基吡咯烷衍生物
CN1052482C (zh) 喜树碱衍生物及其制备方法和抗肿瘤剂
CN1042132C (zh) N－肉桂酰基－2－甲基－5－甲氧基－3－吲哚乙酸酯、其制造方法及含有这种化合物的药物组合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee